The nation of Zimbabwe has rejected a substantial American healthcare agreement worth $367m (£272m) over five years over Washington's request for confidential data.
This move was revealed after a official document dated December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesman later clarified that the US was requesting health data for scientific study and profit but was unwilling to guarantee the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for continued dialogue to reach a agreement agreeable to both sides so the country's critical HIV treatment initiative can proceed.
Wider Background
Zimbabwe's decision follows a similar situation in Kenya, where a court blocked a related health funding agreement following concerns were filed about the security of Kenyans' health data.
Since returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and accountability.
According to statements, 16 nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"In essence, our country would supply the basic resources for scientific discovery without any assurance that the final treatments would be available to our citizens if a new pandemic emerge."
National Interest and Global Health
He also noted that the American exit from the global health body and its push of bilateral deals were undermining systems previously established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to deal with future pandemics.
"This framework is intended to ensure that when a country contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to develop them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome ongoing dialogue with our American counterparts on how future co-operation might be arranged in a manner that respects the sovereignty and interests of both nations."
Health Experts Reaction
Medical experts stated it understood the government's concerns, but recommended that talks should continue considering much of the country's HIV programmes were funded by external financing.
"If specific concerns arise, including those involving data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," it said.
This impasse underscores the complex challenges between receiving crucial international aid and protecting national sovereignty in an increasingly interconnected world.